myTomorrows, a global health technology company connecting patients with all possible treatment options, today announced a new partnership with brainstrust, a UK-based charity that helps people living with a brain tumor reach their potential and thrive. Under the new partnership, people with brain tumors will be equipped with the means to bolster their knowledge of relevant treatment options, potentially extending to participation in clinical trials and access to pre-approval drugs. Moreover, the partnership provides a new layer of support to clinicians in their efforts to recruit patients to relevant clinical trials. There are 80,000 people living with a brain tumor in England alone, with a patient receiving a diagnosis every two hours. Brain tumors kill more children and adults under the age of 40 than any other cancer, and incidences and deaths from brain tumors are on the rise. With… 

When you hear the words E. coli or Salmonella, you immediately think of food poisoning. Rapid detection of such bacteria is crucial for preventing foodborne outbreaks. While it is common to bring food samples to a laboratory to determine the type and amount of bacteria that grow in a petri dish over a period of several days, a research team at Osaka Metropolitan University has developed a portable device for rapid on-site detection. Led by Professor Hiroshi Shiigi of the Graduate School of Engineering, the team experimented with a biosensor that can detect multiple pathogenic bacteria simultaneously within an hour. “The palm-sized detection device can be connected to a smartphone app to easily check the degree of bacterial contamination,” explained Professor Shiigi. His team synthesized organic-metal nanohybrids of gold and copper that mutually ...